Advertisement

Thyroid and Aging

  • Mouhammed Habra
  • Nicholas J. Sarlis
Article

Key words

aging deiodinase hyperthyroidism hypothyroidism thyrotoxicosis thyrotropin thyroid function tests thyroid hormone thyroid nodules thyroid cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous. Statistics on the Aging Population. Administration on Aging. US Department of Health and Human Services,Rockville,MD,2003.Google Scholar
  2. 2.
    Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf)1995;43:55–68.Google Scholar
  3. 3.
    Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985;145:1386–1388.Google Scholar
  4. 4.
    Donda A, Reymond MJ, Lemarchand-Beraud T. Influence of age on the control of thyrotropin secretion by thyrotropin-releasing hormone in the male rat. Neuroendocrinology 1989;49:389–394.Google Scholar
  5. 5.
    Gonzalez E, Quadri SK. Effects of aging on the pituitary-thyroid axis in the dog. Exp Gerontol 1988;23:151–160.Google Scholar
  6. 6.
    Iovino M, Steardo L, Monteleone P. Impaired sensitivity of the hypothalamo-pituitary-thyroid axis to the suppressant effect of dexamethasone in elderly subjects. Psychopharmacology (Berl)1991;105:481–484.Google Scholar
  7. 7.
    Vosberg H, Wagner H, Bockel K, Hauss WH [Age-dependent changes of hypophysis-thyroid-regulation (author’s translation)]. Aktuelle Gerontol 1976;6:279–284 (in German).Google Scholar
  8. 8.
    Monzani F, Del Guerra P, Caraccio N, et al. Age-related modifications in the regulation of the hypothalamic-pituitary-thyroid axis. Horm Res1996;46:107–112.Google Scholar
  9. 9.
    Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab 1991;73:843–849.Google Scholar
  10. 10.
    Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991;151:165–168.Google Scholar
  11. 11.
    Kabadi UM, Rosman PM. Thyroid hormone indices in adult healthy subjects: no influence of aging. J Am Geriatr Soc 1988;36:312–316.Google Scholar
  12. 12.
    Donda A, Lemarchand-Beraud T. Aging alters the activity of 5′-deiodinase in the adenohypophysis, thyroid gland, and liver of the male rat. Endocrinology 1989;124:1305–1309.Google Scholar
  13. 13.
    Correa da Costa VM, Rosenthal D. Effect of aging on thyroidal and pituitary T4-5′-deiodinase activity in female rats. Life Sci1996;59:1515–1520.Google Scholar
  14. 14.
    Greeley GH, Jr., Lipton MA, Kizer JS. Serum thyroxine, triiodothyronine, and TSH levels and TSH release after TRH in aging male and female rats. Endocr Res Commun1982;9:169–177.Google Scholar
  15. 15.
    Feit H. Thyroid function in the elderly. Clin Geriatr Med1988; 4:151–161.Google Scholar
  16. 16.
    Elte JW, Bussemaker JK, Termorshuizen W, Goslings BM, Roelfsema F. Iodine kinetics in patients with euthyroid multinodular goitre compared with normal subjects. Acta Endocrinol (Copenh)1983;104:307–312.Google Scholar
  17. 17.
    Hegedus L, Perrild H, Poulsen LR, et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab1983;56:260–263.Google Scholar
  18. 18.
    Wesche MF, Wiersinga WM, Smits NJ. Lean body mass as a determinant of thyroid size. Clin Endocrinol (Oxf) 1998;48:701–706.Google Scholar
  19. 19.
    Schlienger JL, Goichot B, Grunenberger F, Sapin R.[Thyroid function and dysfunction in the elderly]. Rev Med Interne1996;17:653–360 (in French).Google Scholar
  20. 20.
    Goichot B, Schlienger JL, Grunenberger F, Pradignac A, Sapin R. Thyroid hormone status and nutrient intake in the free-living elderly. Interest of reverse triiodothyronine assessment. Eur J Endocrinol 1994;130:244–252.Google Scholar
  21. 21.
    Spaulding SW, Chopra IJ, Sherwin RS, Lyall SS.1976 Effect of caloric restriction and dietary composition of serum T3 and reverse T3 in man. J Clin Endocrinol Metab1976;42:197–200.Google Scholar
  22. 22.
    Burmeister LA. Reverse T3 does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome. Thyroid 1995;5:435–441.Google Scholar
  23. 23.
    Rodriguez-Espinosa J, Urgell E, Montesinos J, Domingo P, Webb SM. Transient pituitary hypothyroidism in a patient with ectopic adrenocorticotrophic hormone secretion.Ann Clin Biochem2000;37 (Pt 3):298–303.Google Scholar
  24. 24.
    Karga H, Papaioannou P, Venetsanou K, et al. The role of cytokines and cortisol in the non-thyroidal illness syndrome following acute myocardial infarction. Eur J Endocrinol2000;142:236–242.Google Scholar
  25. 25.
    Davies PH, Black EG, Sheppard MC, Franklyn JA. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol (Oxf) 1996;44:199–205.Google Scholar
  26. 26.
    De Jongh FE, Jobsis AC, Elte JW. Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur J Endocrinol2001;144:221–226.Google Scholar
  27. 27.
    De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999;84:151–164.Google Scholar
  28. 28.
    Hennemann G, Krenning EP. Pitfalls in the interpretation of thyroid function tests in old age and non-thyroidal illness. Horm Res 1987;26:100–104.Google Scholar
  29. 29.
    Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979;300:579–584.Google Scholar
  30. 30.
    Lim VS, Tsalikian E, Flanigan MJ. Augmentation of protein degradation by L-triiodothyronine in uremia. Metabolism1989;38:1210–1215.Google Scholar
  31. 31.
    Becker RA, Vaughan GM, Ziegler MG, et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med1982;10:870–875.Google Scholar
  32. 32.
    Stathatos N, Levetan C, Burman KD, Wartofsky L. The controversy of the treatment of critically ill patients with thyroid hormone.Best Pract Res Clin Endocrinol Metab 2001;15:465–478.Google Scholar
  33. 33.
    Angstwurm MW, Schopohl J, Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol 2004;151:47–54.Google Scholar
  34. 34.
    Utiger RD. Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med1995;333:1562–1563.Google Scholar
  35. 35.
    Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998;135:187–196.Google Scholar
  36. 36.
    Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91–95.Google Scholar
  37. 37.
    Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med1995;333:1522–1527.Google Scholar
  38. 38.
    Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986;63:1–8.Google Scholar
  39. 39.
    Gittoes NJ, Franklyn JA. Drug-induced thyroid disorders. Drug Saf 1995;13:46–55.Google Scholar
  40. 40.
    Martino E, Aghini-Lombardi F, Bartalena L, et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med1994;154:2722–2726.Google Scholar
  41. 41.
    Nademanee K, Singh BN, Callahan B, Hendrickson JA, Hershman JM. Amiodarone, thyroid hormone indexes, and altered thyroid function:long-term serial effects in patients with cardiac arrhythmias.Am J Cardiol 1986; 58:981–986.Google Scholar
  42. 42.
    Harjai KJ, Licata AA. Effects of amiodarone on thyroid function.Ann Intern Med 1997;126:63–73.Google Scholar
  43. 43.
    Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachatre G. Relationship between psychotropic drugs and thyroid function: a review. Toxicol Appl Pharmacol 1998;149:127–135.Google Scholar
  44. 44.
    Miyamoto J. Sex steroids and thyroid function tests: the role of estrogen and progestogen. Int J Gynaecol Obstet1978;16:28–33.Google Scholar
  45. 45.
    Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200–2211.Google Scholar
  46. 46.
    Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol (Oxf) 1988;29:63–75.Google Scholar
  47. 47.
    Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. Br Med J 2001;323:891–895.Google Scholar
  48. 48.
    Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002;87:1533–1538.Google Scholar
  49. 49.
    Kong WM, Sheikh MH, Lumb PJ, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002;112:348–354.Google Scholar
  50. 50.
    Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–534.Google Scholar
  51. 51.
    Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160:1573–1575.Google Scholar
  52. 52.
    Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease:scientific review and guidelines for diagnosis and management.JAMA 2004;291:228–238.Google Scholar
  53. 53.
    Mohandas R, Gupta KL. Managing thyroid dysfunction in the elderly. Answers to seven common questions. Postgrad Med2003;113:54–56.Google Scholar
  54. 54.
    Riniker M, Tieche M, Lupi GA, Grob P, Studer H, Burgi H. Prevalence of various degrees of hypothyroidism among patients of a general medical department. Clin Endocrinol (Oxf)1981;14:69–74.Google Scholar
  55. 55.
    Hurley DL, Gharib H. Detection and treatment of hypothyroidism and Graves’ disease. Geriatrics 1995;50:41–44.Google Scholar
  56. 56.
    Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf)1991;34:77–83.Google Scholar
  57. 57.
    Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285–292.Google Scholar
  58. 58.
    Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid: the use of thyroid hormone in older persons. JAMA 1989;261:2653–2655.Google Scholar
  59. 59.
    Doucet J, Trivalle C, Chassagne P, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc1994;42:984–986.Google Scholar
  60. 60.
    Davidoff F, Gill J. Myxedema madness: psychosis as an early manifestation of hypothyroidism. Conn Med 1977;41:618–621.Google Scholar
  61. 61.
    Cook DM, Boyle PJ. Rapid reversal of myxedema madness with triiodothyronine. Ann Intern Med 1986;104:893–894.Google Scholar
  62. 62.
    Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid. Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Am J Med 1985;79:591–595.Google Scholar
  63. 63.
    Fraser SA, Kroenke K, Callahan CM, Hui SL, Williams JW, Jr., Unutzer J. Low yield of thyroid-stimulating hormone testing in elderly patients with depression. Gen Hosp Psychiatry2004;26:302–309.Google Scholar
  64. 64.
    Hunter I, Greene SA, MacDonald TM, Morris AD. Prevalence and aetiology of hypothyroidism in the young. Arch Dis Child2000;83:207–210.Google Scholar
  65. 65.
    Tieche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H, Burgi H. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J1981;46:202–206.Google Scholar
  66. 66.
    Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591–2599.Google Scholar
  67. 67.
    Cooper DS. Thyroid disease in the oldest old: the exception to the rule. JAMA 2004;292:2651–2644.Google Scholar
  68. 68.
    Anderson GH, Jr., Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens1994;12:609–615.Google Scholar
  69. 69.
    Streeten DH, Anderson GH, Jr., Howland T, Chiang R, Smulyan H. Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 1988;11:78–83.Google Scholar
  70. 70.
    Aronow WS. The heart and thyroid disease. Clin Geriatr Med1995;11:219–229.Google Scholar
  71. 71.
    Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med 1983;143:893–897.Google Scholar
  72. 72.
    Fein HG, Rivlin RS. Anemia in thyroid diseases. Med Clin North Am 1975;59:1133–1145.Google Scholar
  73. 73.
    Sarlis NJ, Gourgiotis L. Thyroid emergencies. Rev Endocr Metab Dis 2003;4:129–136.Google Scholar
  74. 74.
    Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983;75:206–209.Google Scholar
  75. 75.
    Gambert SR. Hyperthyroidism in the elderly. Clin Geriatr Med1995;11:181–188.Google Scholar
  76. 76.
    Levy EG. Thyroid disease in the elderly. Med Clin North Am1991;75:151–167.Google Scholar
  77. 77.
    Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients.J Am Geriatr Soc 1996;44:50–53.Google Scholar
  78. 78.
    Yamada T, Aizawa T, Koizumi Y, Komiya I, Ichikawa K, Hashizume K. Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves’ disease. J Am Geriatr Soc1994;42:513–516.Google Scholar
  79. 79.
    Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001;358:861–865.Google Scholar
  80. 80.
    Dobert N, Hamscho N, Menzel C, et al. Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET.Acta Med Austriaca 2003;30:130–133.Google Scholar
  81. 81.
    Allahabadia A, Daykin J, Holder RL, Sheppard MC, Gough SC, Franklyn JA. Age and gender predict the outcome of treatment for Graves’ hyperthyroidism. J Clin Endocrinol Metab2000;85:1038–1042.Google Scholar
  82. 82.
    Kennedy JW, Caro JF. The ABCs of managing hyperthyroidism in the older patient. Geriatrics 1996;51:22–32.Google Scholar
  83. 83.
    Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves’ disease. J Clin Endocrinol Metab1990;70:1518–1524.Google Scholar
  84. 84.
    Shafer RB, Nuttall FQ. Acute changes in thyroid function in patients treated with radioactive iodine. Lancet1975;ii:635–637.Google Scholar
  85. 85.
    Werner RS, Romaldini JH, Farah CS, Werner MC, Bromberg N. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves’disease. Thyroid 1991;1:293–299.Google Scholar
  86. 86.
    Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med 1983;98:26–29.Google Scholar
  87. 87.
    Wiest PW, Hartshorne MF, Inskip PD, et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 1998;17:487–496.Google Scholar
  88. 88.
    Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259–277.Google Scholar
  89. 89.
    Carpi A, Nicolini A, Casara D, Rubello D, Rosa-Pelizzo M. Nonpalpable thyroid carcinoma: clinical controversies on preoperative selection. Am J Clin Oncol 2003;26:232–235.Google Scholar
  90. 90.
    Sherman SI. Thyroid carcinoma. Lancet 2003;361:501–511.Google Scholar
  91. 91.
    DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995;80:2946–2953.Google Scholar
  92. 92.
    Brierley JD, Tsang RW. External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol1999;16:42–49.Google Scholar
  93. 93.
    Sarlis NJ. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research. Curr Drug Targets Immune Endocr Metabol Disord 2001;1:103–115.Google Scholar
  94. 94.
    Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer1996;77:1556–1565.Google Scholar
  95. 95.
    Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Leclerc L, Corcuff B, Guilheme R. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’etude des tumeurs a calcitonine. Clin Endocrinol (Oxf) 1998;48:265–273.Google Scholar
  96. 96.
    Veness MJ, Porter GS, Morgan GJ. Anaplastic thyroid carcinoma:dismal outcome despite current treatment approach. ANZ J Surg 2004;74:559–562.Google Scholar
  97. 97.
    Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg 1999;177:337–339.Google Scholar
  98. 98.
    Kihara M, Miyauchi A, Yamauchi A, Yokomise H. Prognostic factors of anaplastic thyroid carcinoma. Surg Today2004;34:394–398.Google Scholar
  99. 99.
    Voutilainen PE, Multanen M, Haapiainen RK, Leppaniemi AK, Sivula AH. Anaplastic thyroid carcinoma survival. World J Surg1999;23:975–979.Google Scholar
  100. 100.
    McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery2001;130:1028–1034.Google Scholar
  101. 101.
    Widder S, Pasieka JL. Primary thyroid lymphomas. Curr Treat Options Oncol 2004;5:307–313.Google Scholar
  102. 102.
    DiBiase SJ, Grigsby PW, Guo C, Lin HS, Wasserman TH. Outcome analysis for stage IE and IIE thyroid lymphoma. Am J Clin Oncol 2004;27:178–184.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Department of Endocrine Neoplasia & Hormonal DisordersThe University of Texas M. D. Anderson Cancer CenterHoustonUSA
  2. 2.MD, PhD, Associate Professor of Medicine, Department of Endocrine Neoplasia & Hormonal DisordersThe University of Texas M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations